$
₹
$67.710.75% (-0.51)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
32.03
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
2.55
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$2.13
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
1.40
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
8.48%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 10 analysts' reports
Buy9 analysts
Hold1 analyst
Sell0 analyst
Analysts expect a +50.66% price upside over the next year
Current Price$67.71
Target Price$102
Company Profile
Peers
Peers
P/E Ratio
30.76
30.76
1Y Return
8.00%
8.00%
Buy Reco %
—
—
P/E Ratio
37.16
37.16
1Y Return
15.33%
15.33%
Buy Reco %
92.30
92.30
P/E Ratio
35.53
35.53
1Y Return
13.61%
13.61%
Buy Reco %
57.89
57.89
P/E Ratio
30.57
30.57
1Y Return
4.03%
4.03%
Buy Reco %
61.11
61.11
P/E Ratio
—
—
1Y Return
14.91%
14.91%
Buy Reco %
40.00
40.00
Peers & Comparison
Peers & Comparison
HealthcareMedical Instruments & Supplies
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Merit Medical Systems Inc | 32.03 | 2.55 | 1.40 |
| Medline Inc. Class A Common Stock | 30.76 | 3.32 | - |
| West Pharmaceutical Services Inc | 37.16 | 5.73 | 3.08 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Revenue
Net Income
| Financial Year | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 315.23 | 323.28 | 323.50 | 338 | 339.84 | 355.15 | 355.35 | 382.46 | 384.15 | 393.93 |
| Gross Profit | 142.19 | 135.19 | 151.71 | 161.1 | 157.53 | 172.98 | 172.02 | 184.48 | 186.41 | 195.35 |
| Net Income | 25.83 | 27.62 | 28.24 | 35.72 | 28.44 | 27.94 | 30.14 | 32.58 | 27.75 | 38 |
| Net Profit Margin | 8.19% | 8.54% | 8.72% | 10.56% | 8.36% | 7.86% | 8.48% | 8.51% | 7.22% | 9.64% |